Longwood Healthcare Leaders San Francisco CEO
Jan 7, 2024
Panel: Innovation in Clinical Trial Design
Panel Moderator:
Murray Aitken, Executive Director, IQVIA Institute
Panelists:
John Glasspool, CEO, Anthos Therapeutics;
Ed Kaye, CEO, Stoke Therapeutics;
Lisa Ricciardi, CEO, Cognition Therapeutics;
Jim Wooldridge, CMO, Immunitas